![Kitch Wilson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kitch Wilson
Investitore di Private Equity presso Pioneer Fund/NY/
Profilo
Kitch Wilson is a professional who has worked as an Advisor at Bell Biosystems, Inc. from 2011 to 2014.
Currently, he is a Venture Partner at Pioneer Fund since 2023.
Mr. Wilson has a graduate degree from Stanford University and Duke University School of Medicine.
Posizioni attive di Kitch Wilson
Società | Posizione | Inizio |
---|---|---|
Pioneer Fund/NY/
![]() Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | 01/10/2023 |
Precedenti posizioni note di Kitch Wilson
Società | Posizione | Fine |
---|---|---|
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Consulente / Consigliere | 01/04/2014 |
Formazione di Kitch Wilson
Stanford University | Graduate Degree |
Duke University School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Pioneer Fund/NY/
![]() Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Bell Biosystems, Inc.
![]() Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Kitch Wilson